The European AIDS Treatment Group
The European AIDS Treatment Group (EATG) is a non for profit European network of nationally-based volunteer activists comprising of more than 175 members from 47 countries in Europe. Our members are representatives of different communities affected by HIV/AIDS in Europe. The nature of the EATG implies that it has members all over Europe and sometimes even beyond. There are two kinds of membership:
- Supporting Membership, without voting right
- Ordinary Membership, with voting right, usually granted after 1 year
Since its foundation, the EATG has been at the forefront of the development of the civil society response to the HIV/AIDS epidemic in Europe. It represents and defends the treatment-related interests of people living with HIV/AIDS. Our activities focus on treatment literacy and treatment advocacy. A major goal for EATG when it was founded in 1992 was the simultaneous development of therapies in Europe, including not only antiretroviral therapies, but as well as treatments for opportunistic infections and other AIDS related conditions.
Our members are active in the following countries:
Albania, Armenia, Austria, Belarus, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Kazakhstan, Kosovo, Kyrgyzstan, Latvia, Lithuania, Macedonia, Malta, Netherlands, Poland, Portugal, Romania, Russia, Serbia, Slovenia, Spain, Sweden, Switzerland, Tajikistan, Turkey, Ukraine, United Kingdom, Uzbekistan. We also have members in Canada and US.
The first EATG Long Term Strategy covered the period beween 2007 and 2010. At the end of 2011 EATG published its 2012-2015 Long Term Strategy (as a follow up to the previous 2007-2010 LTS).
Within the framework of the Long Term Strategy a work plan is developed each year. At the end of the year an annual report is published.
The EATG’s Long Term Strategy “Intensifying Our HIV Activism in Europe” focuses on making sure that all people who need have access to affordable medication for HIV, and prevention tools to avoid HIV infection.